Watchdog drops bombshell: COVID mutants being created in labs


A conservative watchdog group named Judicial Watch on April 19, 2023 announced it had received 552 pages of records from the Department of Health and Human Services showing that the National Institutes of Health granting funding for experiments at Wuhan Institute of Virology in China that sought to create mutant COVID variants “to better predict the capacity of our CoVs [coronaviruses] to infect people”.

Eco Health planned to sequence the spike protein from coronaviruses obtained from bats for the purpose of “creating mutants to identify how significantly each would need to evolve to use ACE2,” which is explained as “the receptor to gain entry to human cells”.

Judicial Watch obtained the records through a Freedom of Information Act (FOIA) request it filed in December 2021 for:

All reports submitted by EcoHealth Alliance to NIH or its sub-agencies related to NIH Grant No. 1R01A|110964 titled “Understanding the Risk of Bat Coronavirus Emergence” during the term of the grant.

In the initial “Application for Federal Assistance” submitted on June 5, 2013, by EcoHealth Alliance, a section is titled “Specific Aims,” which notes the intention to create mutant bat viruses and “predict the capacity of our CoVs [coronaviruses] to infect people”:

To understand the risk of zoonotic CoV [coronavirus] emergence, we propose to examine 1) the transmission dynamics of bat-CoVs across the human-wildlife interface; and 2) how this process is affected by CoV evolutionary potential, and how it might force CoV evolution. We will assess the nature and frequency of contact among animals and people in two critical human-animal interfaces: live animal markets in China and people who are highly exposed to bats in rural China.

In the continuing discussion of the aims of the research, the report states:

In vitro [outside the body] cell lines & Humanized mouse model: We have developed primary cell lines and transformed cell lines from 9 bat species using kidney, spleen, heart, brain and intestine. We have used these for virus isolation, infection assays and receptor molecule gene cloning. We also have a large number of cell lines from humans and animals that we will use for virus infectivity assays. We have obtained a letter of support from Dr Ralph Baric, who is keen to collaborate with us initially to infect his humanized mouse model with our bat SL-CoV [SARS-Like Coronavirus] that uses ACE2, and subsequently to use other CoVs that we identify…

EcoHealth Alliance’s US$3.3 million grant to fund a project titled “Understanding the Risk of Coronavirus Emergence” was initially to run from October 1, 2013, to September 30, 2018. The first “Project/Performance Site Location” is the Wuhan Institute of Virology. Three other Chinese sites follow: East China Normal University in Shanghai, Yunnan Institute of Endemic Disease Control and Prevention in Dali, and the Center for Disease Control and Prevention of Guangdong in Guangzhou.

On May 27, 2014, the NIH awarded EcoHealth Alliance US$3,086,735 over five years for “Understanding the Risk of Bat Coronavirus Emergence”.

An EcoHealth Alliance grant application, received by the NIH on June 5, 2013, includes a list of “Senior/Key Personnel” including Shi Zhengli and Zhang Yun-Zhi of the Wuhan Institute of Virology (WIV); Peter Daszak, CEO of EcoHealth Alliance; and other Chinese scientists, including Ke Changwen of the Chinese “CDC and Prevention of Guangdong Province”.

A section of the EcoHealth Alliance application titled “EcoHealth Alliance Budget Justification” describes some of the work to be conducted by EcoHealth scientists in China:

A research scientist will be hired at 12 months’ time per year to provide direct assistance and oversight of field activities in China; maintain equipment and logistics; and coordinate animal and human sample shipment to the labs in China and in the US.

In a budget calculation for the year 2014-15, the Wuhan Institute of Virology as a sub-awardee of the grant was allocated to receive US$128,718 in direct costs and US$10,297 in indirect costs from NIH. The salaries of Shi Zhengli and a Wuhan Institute of Virology colleague Ge Xingyl are redacted from the budget. Over the five years of the grant, the Wuhan lab was to receive US$749,976.

Big Pharma companies also investing in creating COVID mutant

Large pharmaceutical companies which have made billions of dollars by selling COVID-19 vaccines and booster doses have made massive profits during 2021-2022, which has encouraged them in now investing heavily in generating “strong mutants” which can “easily infect” individuals and the virus can continue to devastate the world for years, so that those companies can make billions by making everyone in the world victims of such pharma terror. According to several sources, Ukrainian biolabs are being initially selected by those pharma giants, while Russia also is working on generating similar lethal mutants in their secret labs.


Please enter your comment!
Please enter your name here